Search results
Results from the WOW.Com Content Network
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers.The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry.
Current Cancer Drug Targets; Current Oncology; CytoJournal; D. ... Journal of Environmental Science and Health, Part C; Journal of Experimental & Clinical Cancer ...
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001.
Current Drug Metabolism; Current Opinion in Pharmacology; Current Pharmaceutical Design; Current Trends in Biotechnology and Pharmacy; DARU Journal of Pharmaceutical Sciences; Drug Delivery; Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety ...
A. The AAPS Journal; AAPS PharmSciTech; Acta Facultatis Pharmaceuticae Universitatis Comenianae; Advanced Drug Delivery Reviews; Advances in Therapy; Alimentary Pharmacology & Therapeutics
Drug Discovery Today is a monthly peer-reviewed scientific journal that is published by Elsevier.It was established in 1996 and publishes reviews on all aspects of preclinical drug discovery from target identification and validation through hit identification, lead identification and optimisation, to candidate selection.
Journal of Drug Targeting is a peer-reviewed medical journal published by Informa that covers research on all aspects of drug delivery and drug targeting for molecular and macromolecular drugs. The editor in chief is Saghir Akhtar (College of Medicine, Qatar University ).
Drug Target Insights is a peer-reviewed open access academic journal focusing on drug treatment targets and clinical therapeutics. The journal was founded in 2006 by Monica Milani and is currently edited by Giulio Zuanetti. It was originally published by Libertas Academica, but SAGE Publications became the publisher in September 2016. [1]